|
|
|
Insider
Information: |
Bischofberger Norbert W |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,846,606 |
|
Indirect Shares
|
7,743,294 |
|
|
Direct
Value |
$1,259,821 |
|
|
Indirect Value
|
$148,965,006 |
|
|
Total
Shares |
10,589,900 |
|
|
Total
Value |
$150,224,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VIR |
Vir Biotechnology, Inc. |
Director |
|
2024-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
16,000 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2007-10-26 |
4/A |
S |
$46.37 |
$927,461 |
I/I |
(20,000) |
154,944 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2007-10-29 |
4/A |
GD |
$0.00 |
$0 |
I/I |
5,550 |
149,394 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-02-08 |
4 |
S |
$44.40 |
$7,063,189 |
D/D |
(158,820) |
1,062,733 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-02-08 |
4 |
OE |
$8.94 |
$2,089,250 |
D/D |
170,000 |
1,221,553 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
1,075,733 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-04-30 |
4 |
S |
$52.00 |
$4,154,278 |
D/D |
(79,816) |
1,145,917 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-04-30 |
4 |
OE |
$15.27 |
$2,289,750 |
D/D |
150,000 |
1,225,733 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-04-30 |
4 |
S |
$52.02 |
$1,562,329 |
I/I |
(30,000) |
119,394 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-04-30 |
4 |
S |
$52.10 |
$3,658,304 |
D/D |
(70,184) |
1,075,733 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-07-24 |
4 |
OE |
$15.27 |
$2,289,750 |
D/D |
150,000 |
1,226,525 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-07-24 |
4 |
S |
$52.07 |
$7,810,530 |
D/D |
(150,000) |
1,076,525 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-07-24 |
4 |
S |
$52.15 |
$1,564,356 |
I/I |
(30,000) |
89,394 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-11-07 |
4 |
OE |
$15.27 |
$2,289,750 |
D/D |
150,000 |
1,226,525 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-11-07 |
4 |
S |
$45.10 |
$6,765,330 |
D/D |
(150,000) |
1,076,525 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-11-07 |
4 |
S |
$44.75 |
$1,790,000 |
I/I |
(40,000) |
49,394 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2008-11-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
44,394 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-02-04 |
4 |
S |
$52.43 |
$9,096,634 |
D/D |
(173,452) |
1,076,525 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-02-04 |
4 |
OE |
$15.27 |
$2,662,645 |
D/D |
173,452 |
1,249,977 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-02-05 |
4 |
OE |
$15.27 |
$99,955 |
D/D |
6,548 |
1,083,073 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-03-12 |
4 |
D |
$44.04 |
$261,950 |
D/D |
(5,948) |
1,090,125 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
1,096,073 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-05-21 |
4 |
OE |
$16.01 |
$1,601,000 |
D/D |
100,000 |
1,190,125 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-05-21 |
4 |
S |
$42.61 |
$4,260,880 |
D/D |
(100,000) |
1,090,125 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
|
2009-05-21 |
4 |
S |
$42.64 |
$1,279,341 |
I/I |
(30,000) |
14,394 |
0 |
- |
|
193 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|